| Fund ID | 805-8700205607 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 100% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 12% |
| Fund | Type | Gross assets |
|---|---|---|
| Clarendon Investment Partners II, L.P. | Private Equity | $901.1M |
| Bcip Associates Ii-S | Hedge | $666.1M |
| Bcip Real Estate Associates | Real Estate | $345.8M |
Bcip Life Sciences Associates reports $127.2 million in gross assets, among the top 38% of private funds by size.
Bcip Life Sciences Associates is managed by Bain Capital Asset Management, LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.